Duloxetine effective in the treatment of diabetic peripheral neuropathic pain

被引：0
|
作者：
Quilici, S.
Chancellor, J.
Loethgren, M.
机构：
来源：
SA PHARMACEUTICAL JOURNAL | 2009年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [41] Duloxetine in the management of diabetic peripheral neuropathic pain (DPNP): Temporal profile of treatment emergent adverse events
    Schoenberger, E
    Robinson, M
    Shen, SY
    Gonzales, J
    Myers, T
    Brunton, S
    NEUROLOGY, 2006, 66 (05) : A203 - A204
  • [42] Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of peripheral diabetic neuropathic pain
    Quilici, S.
    Chancellor, J.
    Lothgren, M.
    Simon, D.
    Said, G.
    Le, T. K.
    Garcia-Cebrian, A.
    Monz, B.
    Kajdasz, D.
    VALUE IN HEALTH, 2006, 9 (06) : A328 - A328
  • [43] Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
    Sibilia Quilici
    Jeremy Chancellor
    Mickael Löthgren
    Dominique Simon
    Gérard Said
    Trong Kim Le
    Ana Garcia-Cebrian
    Brigitta Monz
    BMC Neurology, 9
  • [44] Duloxetine as treatment for diabetic peripheral neuropathic pain: Results from all placebo-controlled studies
    Wernicke, Joachim
    Pritchett, Yili
    Shen, Shuyi
    Robinson, Michael
    Hall, Jerry
    DIABETES, 2006, 55 : A510 - A510
  • [45] Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
    Quilici, Sibilia
    Chancellor, Jeremy
    Loethgren, Mickael
    Simon, Dominique
    Said, Gerard
    Le, Trong Kim
    Garcia-Cebrian, Ana
    Monz, Brigitta
    BMC NEUROLOGY, 2009, 9
  • [46] Indirect meta-analysis of duloxetine versus pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
    Quilici, S.
    Chancellor, J.
    Lothgren, M.
    Simon, D.
    Said, G.
    Le, T. K.
    Garcia-Cebrian, A.
    Monz, B.
    Kajdasz, D.
    JOURNAL OF NEUROLOGY, 2006, 253 : 108 - 108
  • [47] Cost-effectiveness of duloxetine versus routine treatment for US patients with diabetic peripheral neuropathic pain
    Wu, Eric Q.
    Birnbaum, Howard G.
    Mareva, Milena N.
    Le, T. Kim
    Robinson, Rebecca L.
    Rosen, Amy
    Gelwicks, Steve
    JOURNAL OF PAIN, 2006, 7 (06): : 399 - 407
  • [48] Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions
    Wernicke, Joachim F.
    Prakash, Apurva
    Kajdasz, Daniel K.
    Houston, John
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (05) : 349 - 359
  • [49] Fulranumab for treatment of diabetic peripheral neuropathic pain
    Wang, Hao
    Romano, Gary
    Frustaci, Mary Ellen
    Bohidar, Norm
    Ma, Huizhong
    Sanga, Panna
    Ness, Seth
    Russell, Lucille J.
    Fedgchin, Margaret
    Kelly, Kathleen M.
    Thipphawong, John
    NEUROLOGY, 2014, 83 (07) : 628 - 637
  • [50] Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China
    Gao Yan
    Ning Guang
    Jia Wei-ping
    Zhou Zhi-guang
    Xu Zhang-rong
    Liu Zhi-min
    Liu Chao
    Ma Jian-hua
    Li Qiang
    Cheng Lu-lu
    Wen Chong-yuan
    Zhang Shu-yu
    Zhang Qi
    Desaiah, Durisala
    Skljarevski, Vladimir
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3184 - 3192
12345